U.S. flag

An official website of the United States government

FIBRINOGEN PARIS 1 AND FGG-related disorder

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Nov 21, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003934838.1

Allele description [Variation Report for FIBRINOGEN PARIS 1]

FIBRINOGEN PARIS 1

Gene:
FGG:fibrinogen gamma chain [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
4q32.1
Genomic location:
Preferred name:
FIBRINOGEN PARIS 1
HGVS:
  • NC_000004.12:g.154606073T>C
  • NG_008834.1:g.11678A>G
  • NM_000509.6:c.1129+632A>G
  • NM_021870.2:c.1129+632A>G
  • NM_021870.3:c.1129+632A>GMANE SELECT
  • LRG_585t1:c.1129+632A>G
  • LRG_585t2:c.1129+632A>G
  • LRG_585:g.11678A>G
  • NC_000004.11:g.155527225T>C
  • NM_000509.5:c.1129+632A>G
  • NM_021870.3:c.1129+632A>G
Links:
OMIM: 134850.0011; dbSNP: rs2066862
NCBI 1000 Genomes Browser:
rs2066862
Molecular consequence:
  • NM_000509.6:c.1129+632A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_021870.3:c.1129+632A>G - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
FGG-related disorder
Synonyms:
FGG-related condition
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004747242PreventionGenetics, part of Exact Sciences
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Nov 21, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From PreventionGenetics, part of Exact Sciences, SCV004747242.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The FGG c.1129+632A>G variant is predicted to interfere with splicing. This variant (as n.6588A>G) was reported in an individual with Dysfibrinogenaemia and was functionally shown to result in the insertion of a 45 bp fragment between exons 8 and 9 during splicing (Rosenberg et al. 1993. PubMed ID: 8470043). This variant is reported in 1.0% of alleles in individuals of Ashkenazi Jewish descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 15, 2024